Harvard Perspectives on Prostate Disease

Choosing - and sticking with - active surveillance: A patient's story

Choosing — and sticking with — active surveillance: A patient's story

In 1997, Jeffrey Caruso's physician recommended prostate-specific antigen (PSA) screening as part of Caruso's annual checkup. Then a 57-year-old businessman and avid bicyclist, Caruso* hadn't had any prostate problems, but he agreed that regular PSA screening was probably wise for someone his age. The result — 3.9 ng/ml — raised some concern because it fell at the upper end of what was considered the normal PSA range: 0 to 4.0 ng/ml.

*Editor's note: To protect his privacy, the patient's name and some biographical details have been changed. All medical details are as reported. In keeping with editorial policy, the patient's physicians are not named.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »